BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34480081)

  • 1. Solid papillary mesothelial tumor.
    Churg A; Le Stang N; Dacic S; Pissaloux D; Begueret H; Dartigues P; Giusiano-Courcambeck S; Sequeiros R; Pairon JC; Tirode F; Galateau-Sallé F
    Mod Pathol; 2022 Jan; 35(1):69-76. PubMed ID: 34480081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
    Goldblum J; Hart WR
    Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.
    Stevers M; Rabban JT; Garg K; Van Ziffle J; Onodera C; Grenert JP; Yeh I; Bastian BC; Zaloudek C; Solomon DA
    Mod Pathol; 2019 Jan; 32(1):88-99. PubMed ID: 30171198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
    Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
    Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of diffuse malignant peritoneal mesothelioma.
    Hung YP; Dong F; Torre M; Crum CP; Bueno R; Chirieac LR
    Mod Pathol; 2020 Nov; 33(11):2269-2279. PubMed ID: 32504035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
    Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
    Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of localized pleural mesothelioma.
    Hung YP; Dong F; Dubuc AM; Dal Cin P; Bueno R; Chirieac LR
    Mod Pathol; 2020 Feb; 33(2):271-280. PubMed ID: 31371807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.
    Hung YP; Chirieac LR
    Arch Pathol Lab Med; 2024 May; 148(5):e77-e89. PubMed ID: 38190277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
    Brich S; Bozzi F; Perrone F; Tamborini E; Cabras AD; Deraco M; Stacchiotti S; Dagrada GP; Pilotti S
    Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
    Dermawan JK; Torrence D; Lee CH; Villafania L; Mullaney KA; DiNapoli S; Sukhadia P; Benayed R; Borsu L; Agaram NP; Nash GM; Dickson BC; Benhamida J; Antonescu CR
    Genes Chromosomes Cancer; 2022 Oct; 61(10):592-602. PubMed ID: 35665561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
    Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
    JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
    Cigognetti M; Lonardi S; Fisogni S; Balzarini P; Pellegrini V; Tironi A; Bercich L; Bugatti M; Rossi G; Murer B; Barbareschi M; Giuliani S; Cavazza A; Marchetti G; Vermi W; Facchetti F
    Mod Pathol; 2015 Aug; 28(8):1043-57. PubMed ID: 26022455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
    Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
    Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenous Spherulosis in Well-Differentiated Papillary Mesothelioma in a Female With Multilocular Peritoneal Inclusion Cysts.
    AbdullGaffar B; Raman LG
    Int J Surg Pathol; 2019 Jun; 27(4):427-431. PubMed ID: 30522362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelioma In Situ Mimicking Well-differentiated Papillary Mesothelial Tumor.
    Galateau-Salle F; Hamilton T; MacNeill A; Hofman V; Sequeiros R; Sagan C; Le Stang N; Churg A
    Am J Surg Pathol; 2023 May; 47(5):611-617. PubMed ID: 36876759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
    Zafar R; Schrader LJ; Cheville JC; Schoolmeester JK; Roden AC; Aubry MC; Yi ES; Raghunathan A; Herrera-Hernandez L; Thompson RH; Boorjian SA; Leibovich BC; Keeney GL; Jimenez RE; Gupta S
    Hum Pathol; 2022 Oct; 128():31-47. PubMed ID: 35809685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions.
    Önder S; Özogul E; Koksal D; Sarinc Ulasli S; Firat P; Emri S
    Cytopathology; 2019 Nov; 30(6):592-600. PubMed ID: 31165505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
    Churg A; Sheffield BS; Galateau-Salle F
    Arch Pathol Lab Med; 2016 Apr; 140(4):318-21. PubMed ID: 26288396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas.
    Clement PB; Young RH; Scully RE
    Am J Surg Pathol; 1996 Sep; 20(9):1067-80. PubMed ID: 8764743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal adenomatoid (microcystic) mesothelioma.
    Mori D; Kido S; Hiraki M; Sumi K; Ureshino N; Masuda M; Nabeshima K; Akashi M
    Pathol Int; 2020 Nov; 70(11):876-880. PubMed ID: 32881200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.